• Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu861Gln (c.2582T>A); ClinVar=VCV000163380; Zygosity=Unspecified (PubMed=31882684).
  

PubMed=31882684; DOI=10.1038/s41598-019-56356-4; PMCID=PMC6934824
Seok-Young Kim, Ji Yeon Lee, Dong Hwi Kim, Hyeong-Seok Joo, Mi Ran Yun, Dongmin Jung, Jiyeon Yun, Seong Gu Heo, Beung-Chul Ahn, Chae Won Park, Kyoung Ho Pyo ...Show all 15 authors... , You Jin Chun, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho; Show fewer authors
Patient-derived cells to guide targeted therapy for advanced lung adenocarcinoma.
Sci. Rep. 9:19909.1-19909.12(2019)

PubMed=39874964; DOI=10.1016/j.xcrm.2025.101929
Seung Yeon Oh, Soyoung Park, Seoyoung Lee, Eun Ji Lee, Tae Ho Kim, Su-Jin Choi, So Young Park, Jae Hwan Kim, Sun Min Lim, Jii Bum Lee, Byoung Chul Cho ...Show all 13 authors... , Min Hee Hong, Mi Ran Yun; Show fewer authors
The potential of lazertinib and amivantamab combination therapy as a treatment strategy for uncommon EGFR-mutated NSCLC.
Cell Rep. Med. 6:101929.1-101929.12(2025)